Best supportive care in patients with brain metastases and adverse prognostic factors: Development of improved decision aids

Supportive Care in Cancer

Volumn 21, Issue 10, 2013, Pages 2671-2678

  Nieder, Carsten ^a,b   Norum, Jan ^b,c,d   Dalhaug, Astrid ^a,b   Aandahl, Gro ^a   Engljähringer, Kirsten ^a  

^a NORDLAND HOSPITAL   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

^c UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^d NORTHERN NORWAY REGIONAL HEALTH AUTHORITY   (Norway)

Author keywords

Best supportive care; Brain metastases; Prognostic factors; Radiotherapy

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BEST SUPPORTIVE CARE; BRAIN METASTASIS; BRAIN RADIATION; CANCER CONTROL; CANCER PROGNOSIS; CANCER THERAPY; FEMALE; HUMAN; KARNOFSKY PERFORMANCE STATUS; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STEREOTACTIC RADIOSURGERY; SURVIVAL PREDICTION; SURVIVAL RATE;

ADULT; AGED; BRAIN NEOPLASMS; CRANIAL IRRADIATION; DECISION SUPPORT TECHNIQUES; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MODELS, STATISTICAL; PALLIATIVE CARE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RADIOSURGERY; RETROSPECTIVE STUDIES;

EID: 84884289082     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-013-1840-5     Document Type: Article

References (24)

1. Craighead PS, Chan A (2012) Defining treatment for brain metastases patients: nihilism versus optimism. Support Care Cancer 20:279-285
2. Danielson B, Fairchild A (2012) Beyond palliative radiotherapy: a pilot multidisciplinary brain metastases clinic. Support Care Cancer 20:773-781
3. Yamanaka R, Koga H, Yamamoto Y, Yamada S, Sano T, Fukushige T (2011) Characteristics of patients with brain metastases from lung cancer in a palliative care center. Support Care Cancer 19:467-473
4. Langley RE, Stephens RJ, Nankivell M, Pugh C, Moore B, Navani N, Wilson P, Faivre-Finn C, Barton R, Parmar M, Mulvenna PM, Investigators QUARTZ (2013) Interim data from the Medical Research Council QUARTZ trial: does whole brain radiotherapy affect the survival and quality of life of patients with brain metastases from non-small cell lung cancer? Clin Oncol (R Coll Radiol) 25:e23-e30
5. Nieder C, Norum J, Dalhaug A, Aandahl G, Pawinski A (2013) Radiotherapy versus best supportive care in patients with brain metastases and adverse prognostic factors. Clin Exp Metastasis doi: 10.1007/s10585-013-9573-x
6. Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, McKenna WG, Byhart R (1997) Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37:745-751
7. Sperduto PW, Berkey B, Gaspar LE, Mehta M, Curran W (2008) A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database. Int J Radiat Oncol Biol Phys 70:510-514
8. Sperduto PW, Chao ST, Sneed PK, Luo X, Suh J, Roberge D, Bhatt A, Jensen AW, Brown PD, Shih H, Kirkpatrick J, Schwer A, Gaspar LE, Fiveash JB, Chiang V, Knisely J, Sperduto CM, Mehta M (2010) Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. Int J Radiat Oncol Biol Phys 77:655-661
9. Nieder C, Nestle U, Motaref B, Walter K, Niewald M, Schnabel K (2000) Prognostic factors in brain metastases: should patients be selected for aggressive treatment according to recursive partitioning analysis (RPA) classes? Int J Radiat Oncol Biol Phys 46:297-302
10. Nieder C, Marienhagen K, Geinitz H, Molls M (2009) Validation of the graded prognostic assessment index for patients with brain metastases. Acta Oncol 48:457-459
11. Nieder C, Andratschke NH, Geinitz H, Grosu AL (2012) Diagnosis-specific graded prognostic assessment score is valid in patients with brain metastases treated in routine clinical practice in two European countries. Med Sci Monit 18:CR450-CR455
12. Nieder C, Pawinski A, Molls M (2010) Prediction of short survival in patients with brain metastases based on three different scores: a role for 'triple-negative' status? Clin Oncol (R Coll Radiol) 22:65-69
13. Nieder C, Andratschke NH, Geinitz H, Grosu AL (2012) Use of the Graded Prognostic Assessment (GPA) score in patients with brain metastases from primary tumours not represented in the diagnosis-specific GPA studies. Strahlenther Onkol 188:692-695
14. Nieder C, Spanne O, Mehta MP, Grosu AL, Geinitz H (2010) Presentation, patterns of care, and survival in patients with brain metastases: what has changed in the last 20 years? Cancer 117:2505-2512
15. Nieder C, Norum J, Stemland JG, Dalhaug A (2010) Resource utilization in patients with brain metastases managed with best supportive care, radiotherapy and/or surgical resection: a Markov analysis. Oncology 78:348-355
16. Rades D, Evers JN, Veninga T, Stalpers LJ, Lohynska R, Schild SE (2011) Shorter-course whole-brain radiotherapy for brain metastases in elderly patients. Int J Radiat Oncol Biol Phys 81:e467-e473
17. Lagerwaard FJ, Levendag PC, Nowak PJ, Eijkenboom WM, Hanssens PE, Schmitz PI (1999) Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. Int J Radiat Oncol Biol Phys 43:795-803
18. Rades D, Dziggel L, Haatanen T, Veninga T, Lohynska R, Dunst J, Schild SE (2011) Scoring systems to estimate intracerebral control and survival rates of patients irradiated for brain metastases. Int J Radiat Oncol Biol Phys 80:1122-1127
19. Sperduto PW, Kased N, Roberge D, Xu Z, Shanley R, Luo X, Sneed PK, Chao ST, Weil RJ, Suh J, Bhatt A, Jensen AW, Brown PD, Shih HA, Kirkpatrick J, Gaspar LE, Fiveash JB, Chiang V, Knisely JP, Sperduto CM, Lin N, Mehta M (2012) Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases. J Clin Oncol 30:419-425
20. Khan L, Cramarossa G, Lemke M, Nguyen J, Zhang L, Chen E, Chow E (2013) Symptom clusters using the Spitzer quality of life index in patients with brain metastases - a reanalysis comparing different statistical methods. Support Care Cancer 21:467-473
21. Soffietti R, Kocher M, Abacioglu UM, Villa S, Fauchon F, Baumert BG, Fariselli L, Tzuk-Shina T, Kortmann RD, Carrie C, Ben Hassel M, Kouri M, Valeinis E, van den Berge D, Mueller RP, Tridello G, Collette L, Bottomley A (2013) A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results. J Clin Oncol 31:65-72
22. Steinmann D, Vordermark D, Geinitz H, Aschoff R, Bayerl A, Gerstein J, Hipp M, van Oorschot B, Wypior HJ, Schäfer C (2013) Proxy assessment of patients before and after radiotherapy for brain metastases: results of a prospective study using the DEGRO brain module. Strahlenther Onkol 189:47-53
23. Tsao MN, Rades D, Wirth A, Lo SS, Danielson BL, Vichare A, Hahn C, Chang EL (2012) International practice survey on the management of brain metastases: Third International Consensus Workshop on Palliative Radiotherapy and Symptom Control. Clin Oncol (R Coll Radiol) 24:e81-e92
24. Fife KM, Colman MH, Stevens GN, Firth IC, Moon D, Shannon KF, Harman R, Petersen-Schaefer K, Zacest AC, Besser M, Milton GW, McCarthy WH, Thompson JF (2004) Determinants of outcome in melanoma patients with cerebral metastases. J Clin Oncol 22:1293-1300